A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...

"The second class of medications, called 5 alpha-reductase inhibitors, cause the prostate to gradually shrink over time ...

A breakthrough experimental drug has shown promising results in shrinking advanced prostate cancer tumours, offering new hope ...

A new treatment for non-cancerous enlargement of the prostate, a very common condition in older men, has been recommended for use by the NHS. It's called prostate artery embolisation. And it ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone therapy enzalutamide.